147 related articles for article (PubMed ID: 10465341)
1. Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.
Dass SB; Bucci TJ; Heflich RH; Casciano DA
Cancer Lett; 1999 Aug; 143(1):81-5. PubMed ID: 10465341
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of C57BL/6 mice to tumorigenicity induced by dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine in the neonatal bioassay.
Dass SB; Hammons GJ; Bucci TJ; Heflich RH; Casciano DA
Cancer Lett; 1998 Feb; 124(1):105-10. PubMed ID: 9500198
[TBL] [Abstract][Full Text] [Related]
3. Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays.
Spalding JW; French JE; Stasiewicz S; Furedi-Machacek M; Conner F; Tice RR; Tennant RW
Toxicol Sci; 2000 Feb; 53(2):213-23. PubMed ID: 10696769
[TBL] [Abstract][Full Text] [Related]
4. Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice.
Sørensen IK; Mortensen A; Kristiansen E; van Kreijl C; Adamson RH; Thorgeirsson SS
Carcinogenesis; 1996 Oct; 17(10):2221-7. PubMed ID: 8895492
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of liver proliferative lesions in heterozygous p53 deficient CBA mice to various carcinogens.
Uehara T; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Mitsumori K
J Vet Med Sci; 2002 Jul; 64(7):551-6. PubMed ID: 12185306
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nonthreshold leukemogenic response to methyl nitrosourea in p53-deficient C3H/He mice.
Hirabayashi Y; Yoshida K; Aizawa S; Kodama Y; Kanno J; Kurokawa Y; Yoshimura I; Inoue T
Toxicol Appl Pharmacol; 2003 Aug; 190(3):251-61. PubMed ID: 12902196
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
[TBL] [Abstract][Full Text] [Related]
8. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice.
Paulsen JE; Steffensen IL; Andreassen A; Vikse R; Alexander J
Carcinogenesis; 1999 Jul; 20(7):1277-82. PubMed ID: 10383901
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
10. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
[TBL] [Abstract][Full Text] [Related]
11. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
12. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
[TBL] [Abstract][Full Text] [Related]
13. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele.
Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J
Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398
[TBL] [Abstract][Full Text] [Related]
14. Mutational response at the splenic T-lymphocyte hprt locus in mice treated as neonates: contrasting effects of the carcinogens N-ethyl-N-nitrosourea, dimethylnitrosamine, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Dass SB; Heflich RH; Casciano DA
Environ Mol Mutagen; 1998; 31(3):243-7. PubMed ID: 9585262
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma induction by heterocyclic amines in E mu-pim-1 transgenic mice.
Sørensen IK; Kristiansen E; Mortensen A; van Kreijl C; Adamson RH; Thorgeirsson SS
Arch Toxicol Suppl; 1997; 19():377-86. PubMed ID: 9079225
[TBL] [Abstract][Full Text] [Related]
16. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice.
Delker DA; Yano BL; Gollapudi BB
Toxicol Sci; 2000 Jun; 55(2):361-9. PubMed ID: 10828268
[TBL] [Abstract][Full Text] [Related]
18. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
van Steeg H; Klein H; Beems RB; van Kreijl CF
Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular tumor induction in heterozygous p53-deficient CBA mice by a 26-week dietary administration of kojic acid.
Takizawa T; Mitsumori K; Tamura T; Nasu M; Ueda M; Imai T; Hirose M
Toxicol Sci; 2003 Jun; 73(2):287-93. PubMed ID: 12700405
[TBL] [Abstract][Full Text] [Related]
20. Comparative tumorigenicity of nitrochrysene isomers in newborn mice.
el-Bayoumy K; Desai D; Upadhyaya P; Amin S; Hecht SS
Carcinogenesis; 1992 Dec; 13(12):2271-5. PubMed ID: 1473233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
